[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hanna et al., 2020 - Google Patents

Phototherapy as a rational antioxidant treatment modality in COVID-19 management; new concept and strategic approach: critical review

Hanna et al., 2020

View HTML
Document ID
13430376006248299419
Author
Hanna R
Dalvi S
Sălăgean T
Bordea I
Benedicenti S
Publication year
Publication venue
Antioxidants

External Links

Snippet

The COVID-19 pandemic has taken the entire globe by storm. The pathogenesis of this virus has shown a cytokine storm release, which contributes to critical or severe multi-organ failure. Currently the ultimate treatment is palliative; however, many modalities have been …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0009—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation
    • A61K41/0019—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation by UV, IR, Rx or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infra-red
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons

Similar Documents

Publication Publication Date Title
Hanna et al. Phototherapy as a rational antioxidant treatment modality in COVID-19 management; new concept and strategic approach: critical review
Peeples Avoiding pitfalls in the pursuit of a COVID-19 vaccine
de Matos et al. Photobiomodulation therapy as a possible new approach in COVID-19: A systematic review
Maeding et al. Boosting tumor-specific immunity using PDT
Monjo et al. Photodynamic inactivation of herpes simplex viruses
Walpita et al. A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model
Ailioaie et al. Curcumin and photobiomodulation in chronic viral hepatitis and hepatocellular carcinoma
Purushothaman et al. KSHV-mediated angiogenesis in tumor progression
Natekar et al. Cellular microRNA-155 regulates virus-induced inflammatory response and protects against lethal West Nile virus infection
Terasawa et al. Anti-influenza A virus activity of rhamnan sulfate from green algae Monostroma nitidum in mice with normal and compromised immunity
Hepburn et al. A novel approach of combining methylene blue photodynamic inactivation, photobiomodulation and oral ingested methylene blue in COVID-19 management: A pilot clinical study with 12-month follow-up
Del Vecchio et al. Laser photobiomodulation (Pbm)—a possible new frontier for the treatment of oral cancer: A review of in vitro and in vivo studies
Laneri et al. Antimicrobial peptides and physical activity: a great hope against COVID 19
Kitchen et al. Rationale for 1068 nm photobiomodulation therapy (PBMT) as a novel, non-invasive treatment for COVID-19 and other coronaviruses: roles of NO and hsp70
Girotti Modulation of the anti-tumor efficacy of photodynamic therapy by nitric oxide
Souri et al. Anti-COVID-19 nanomaterials: Directions to improve prevention, diagnosis, and treatment
Malik et al. Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies
Pokrovska et al. External beam radiation therapy and enadenotucirev: Inhibition of the DDR and mechanisms of radiation-mediated virus increase
Martu et al. The effectiveness of laser applications and photodynamic therapy on relevant periodontal pathogens (Aggregatibacter actinomycetemcomitans) associated with immunomodulating anti-rheumatic drugs
Ziganshyna et al. Photodynamic inactivation of SARS-CoV-2 infectivity and antiviral treatment effects in vitro
Pasquereau et al. Counteracting Akt activation by HIV protease inhibitors in monocytes/macrophages
Zhukhovitsky et al. Infectivity and morphology of bovine coronavirus inactivated in vitro by cationic photosensitizers
Sutter et al. Manipulation of oxidative stress responses by non-thermal plasma to treat herpes simplex virus type 1 infection and disease
Nair et al. Enhancing antitumor efficacy of heavily vascularized tumors by RAMBO virus through decreased tumor endothelial cell activation
Ailioaie et al. Light as a Cure in COVID-19: A Challenge for Medicine